Channel-fit: Specialized medical providers, telehealth platforms (e.g., LillyDirect), and retail pharmacies CnbcGrandviewresearch
Research and Regulatory Status Approved Use (Native IGF-1): The native recombinant human IGF-1 (Mecasermin) is FDA-approved for growth failure in children with severe IGF-1 deficiency
Large reviews show that people without diabetes can lose about 5 percent to nearly 18 percent of their body weight, depending on the medication, dose, and how long they stay on it
Smolenski S, George NM
The post says the combination is most evidence-supported for people with concurrent insulin resistance, polycystic ovary syndrome, metabolic syndrome, or type 2 diabetes who are seeking weight loss and hormonal stabilization
Privacy protections meet basic standards, but certifications like SOC-2 or HITRUST arent advertised